Lataa...
Circulating tumor DNA for personalized lung cancer monitoring
Advances in deep sequencing technology have led to developments in personalized medicine. Here, we describe the implications of a recent investigation that sequenced ctDNA from the plasma of non-small cell lung cancer patients to develop personalized ctDNA tests. These ‘liquid biopsies’ have shown p...
Tallennettuna:
| Julkaisussa: | BMC Med |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
BioMed Central
2017
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5559853/ https://ncbi.nlm.nih.gov/pubmed/28814291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12916-017-0921-6 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|